Skip to main content
Mangoceuticals, Inc. (MGRX)
NASDAQ: MGRX · Real-Time Price · USD
2.150
+0.200 (10.26%)
At close: Apr 1, 2025, 4:00 PM
2.000
-0.150 (-7.00%)
After-hours: Apr 1, 2025, 7:56 PM EDT

Mangoceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-8.71-9.21-2-0.07
Depreciation & Amortization
0.730.020-
Loss (Gain) From Sale of Assets
0.02---
Stock-Based Compensation
2.352.160.77-
Other Operating Activities
0.080.05-0.150
Change in Inventory
--0.02--
Change in Accounts Payable
0.70.110.03-
Change in Other Net Operating Assets
-0.04-0.1-0.01-
Operating Cash Flow
-4.86-7-1.35-0.07
Capital Expenditures
--0-0.04-
Sale of Property, Plant & Equipment
0.07---
Investing Cash Flow
0.07-0-0.04-
Short-Term Debt Issued
0.15-0.08-
Total Debt Issued
0.15-0.080.16
Short-Term Debt Repaid
--0.17-0.03-
Total Debt Repaid
--0.17-0.03-
Net Debt Issued (Repaid)
0.15-0.170.050.16
Issuance of Common Stock
1.337.2220
Financing Cash Flow
4.137.062.050.16
Foreign Exchange Rate Adjustments
-0.01---
Net Cash Flow
-0.680.060.660.09
Free Cash Flow
-4.86-7-1.39-0.07
Free Cash Flow Margin
-789.74%-957.07%-15545.59%-
Free Cash Flow Per Share
-2.46-6.52-1.93-0.13
Levered Free Cash Flow
-0.93-2.87-0.49-
Unlevered Free Cash Flow
-0.92-2.87-0.49-
Change in Net Working Capital
-1.14-0.03-0.02-
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q